How One Top 20 Pharma Is Driving Operational Process Improvements

As the hub of clinical operations, it is common for a clinical trial management system (CTMS) to have many integrations with other clinical systems and to be deeply embedded across an organization. One top 20 pharma company had a complex multitude of loosely integrated systems, but prioritized digitization to improve the drug development pathway and value chain. Standardizing on a modern CTMS and unified clinical platform enabled it to achieve significant business benefits.

Recent research shows that an overwhelming majority (99%) say bundling CTMS with at least one other clinical technology is critical.¹

That’s why ease of integration with eClinical technologies is the most important criteria for CTMS solutions, followed by ease of use for clinical sites and sponsor/CRO study teams.² Seamless interoperability with other clinical systems is necessary to provide complete visibility and oversight across the end-to-end trial process. There is a tremendous opportunity to reduce system and process silos that limit visibility, quality, and speed.

Providing an easy-to-use, intuitive experience across all clinical operations processes boosts productivity and speeds study execution for the top 20 pharma company, driving exceptional results.